Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Boccalini, Sara
Alicino, Cristiano
Martinelli, Domenico
Bechini, Angela
Tiscione, Emilia
Pellizzari, Barbara
Prato, Rosa
Icardi, Giancarlo
Iannazzo, Stefania
and
Bonanni, Paolo
2017.
Clinical and economic impact of herpes zoster vaccination in elderly in Italy.
Human Vaccines & Immunotherapeutics,
Vol. 13,
Issue. 2,
p.
405.
Hoshi, Shu-ling
Kondo, Masahide
and
Okubo, Ichiro
2017.
Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan.
Vaccine,
Vol. 35,
Issue. 24,
p.
3264.
Blank, Patricia R.
Ademi, Zanfina
Lu, Xiaoyan
Szucs, Thomas D.
and
Schwenkglenks, Matthias
2017.
Herpes zoster vaccine: A health economic evaluation for Switzerland.
Human Vaccines & Immunotherapeutics,
Vol. 13,
Issue. 7,
p.
1495.
Esposito, Susanna
and
Principi, Nicola
2018.
Herpes zoster prevention: A difficult problem to solve.
Vaccine,
Vol. 36,
Issue. 36,
p.
5442.
Bilcke, Joke
Verelst, Frederik
and
Beutels, Philippe
2018.
Sponsorship Bias in Base-Case Values and Uncertainty Bounds of Health Economic Evaluations? A Systematic Review of Herpes Zoster Vaccination.
Medical Decision Making,
Vol. 38,
Issue. 6,
p.
730.
Matthews, Sean
De Maria, Antonio
Passamonti, Marco
Ristori, Giovanni
Loiacono, Idalba
Puggina, Anna
and
Curran, Desmond
2019.
The Economic Burden and Impact on Quality of Life of Herpes Zoster and Postherpetic Neuralgia in Individuals Aged 50 Years or Older in Italy.
Open Forum Infectious Diseases,
Vol. 6,
Issue. 2,
Chiyaka, Edward T.
Nghiem, Van T.
Zhang, Lu
Deshpande, Abhishek
Mullen, Patricia Dolan
and
Le, Phuc
2019.
Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review.
PharmacoEconomics,
Vol. 37,
Issue. 2,
p.
169.
Volpi, Antonio
Boccalini, Sara
Dari, Silvia
Clarke, Christopher
Curran, Desmond
Loiacono, Idalba
Pitrelli, Andrea
Puggina, Anna
Tosatto, Roberta
Van Oorschot, Desirée
and
Franco, Elisabetta
2020.
The potential public health impact of Herpes Zoster vaccination in the 65 years of age cohort in Italy.
Human Vaccines & Immunotherapeutics,
Vol. 16,
Issue. 2,
p.
327.
Udayachalerm, Sariya
Renouard, Maranda G.
Anothaisintawee, Thunyarat
Thakkinstian, Ammarin
Veettil, Sajesh K.
and
Chaiyakunapruk, Nathorn
2022.
Incremental net monetary benefit of herpes zoster vaccination: a systematic review and meta-analysis of cost-effectiveness evidence.
Journal of Medical Economics,
Vol. 25,
Issue. 1,
p.
26.
Barbieri, Marco
and
Boccalini, Sara
2023.
Return on Investment (ROI) of Three Vaccination Programmes in Italy: HPV at 12 Years, Herpes Zoster in Adults, and Influenza in the Elderly.
Vaccines,
Vol. 11,
Issue. 5,
p.
924.